Core Insights - The report by Kearney highlights a significant acceleration in the timeline for Chinese brands to establish recognition overseas, reducing the period from 10 years to 3-5 years due to factors like cross-border e-commerce and social media [1] - The transformation in the paradigm of Chinese consumer goods going global is evident, shifting from merely selling products to building ecosystems and localizing manufacturing [3][4] Group 1: Changes in Globalization Strategy - External uncertainties, such as geopolitical tensions and trade protectionism, have become the new normal for Chinese brands going global, altering their pathways and success logic [3] - The shift from "product export" to "capacity export/local investment" necessitates establishing a complete R&D, production, and marketing loop in target markets [3][4] Group 2: Brand Success Factors - Brands like Pop Mart and Miniso exemplify the transformation in the export paradigm, achieving rapid global consumer engagement through a combination of strategic choices and systemic capabilities [5] - The success of these brands is attributed to their ability to tap into "emotional consumption," driven by the rise of the global Z generation and effective use of social media [5][6] Group 3: Systemic Capabilities - Three core barriers to sustainable advantage are identified: a flexible supply chain for rapid product transformation, integration of content and retail for emotional engagement, and the ability to resonate deeply with local cultures [6] - The current wave of Chinese brand globalization differs from the American model, emphasizing localized narratives and cultural integration rather than standardized outputs [8] Group 4: Comparative Analysis - Similarities between Chinese and American brands include leveraging large domestic markets for global expansion, universal emotional appeals, and the backing of national strength [7] - Key differences lie in the brand establishment cycle, with Chinese brands utilizing advanced infrastructure to shorten this period significantly, and a focus on localized strategies rather than a one-size-fits-all approach [8]

Core Viewpoint - Miniso (09896) announced a share buyback plan, indicating confidence in its stock value and future growth potential [1] Group 1: Company Actions - The company plans to repurchase 51,300 shares at a total cost of $246,500 [1]

智通财经APP讯，名创优品(09896)发布公告，于2026年1月26日，该公司斥资24.65万美元回购5.13万 股。 ...

格隆汇1月27日丨名创优品(09896.HK)发布公告，2026年1月26日耗资24.65万美元回购5.13万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 FF305 第 2 頁 共 7 頁 v 1.3.0 FF305 公司名稱： 名創優品集團控股有限公司 呈交日期： 2026年1月27日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 09896 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | ...

Core Viewpoint - MINISO Group Holding Limited Unsponsored ADR (MNSO) is experiencing a decline in stock price, with a recent trading session closing at $19.13, reflecting a -3.58% change from the previous day, which is underperforming compared to the S&P 500 and other indices [1] Company Performance - The upcoming earnings disclosure is anticipated to show revenue of $859.03 million, representing a 33.05% increase from the prior-year quarter [2] - Full-year estimates project earnings of $1.35 per share and total revenue of $3 billion, indicating year-over-year changes of +17.39% for earnings and 0% for revenue [2] Analyst Estimates - Recent adjustments to analyst estimates for MINISO are being monitored closely, as these revisions reflect short-term business trends and a favorable outlook on the company's health and profitability [3] - The Zacks Rank system, which integrates estimate changes, currently ranks MINISO as 3 (Hold), indicating a neutral outlook [5] Valuation Metrics - MINISO is trading at a Forward P/E ratio of 12.64, which is below the industry average of 18.63, suggesting that the stock may be undervalued [6] - The company has a PEG ratio of 1.31, compared to the industry average of 2.09, indicating a more favorable growth expectation relative to its price [7] Industry Context - The Retail - Apparel and Shoes industry, which includes MINISO, holds a Zacks Industry Rank of 50, placing it in the top 21% of over 250 industries, suggesting strong performance potential [8]

Group 1 - The Nasdaq China Golden Dragon Index fell by over 0.5% on January 26 [2] - Miniso Group saw a decline of 4.08% [2] - Zai Lab Limited experienced a drop of 4.36% [2] - Daqo New Energy Corp decreased by 2.80% [2] - Xpeng Motors fell by 2.70% [2] - Baidu Inc. declined by 2.51% [2]

Market Overview - U.S. stock futures are lower, with Dow futures down approximately 0.1% on Monday [1] Revolution Medicines Inc - Shares of Revolution Medicines Inc (NASDAQ:RVMD) fell 26.1% to $87.02 in pre-market trading following reports that Merck (NYSE:MRK) is no longer in talks to acquire the company [1] Erasca Inc - Erasca Inc (NASDAQ:ERAS) experienced a decline of 11.5%, trading at $8.82 in pre-market after announcing the closing of an upsized public offering of common stock [2] BlackRock TCP Capital Corp - BlackRock TCP Capital Corp (NASDAQ:TCPC) saw a decrease of 8.7%, trading at $5.35 in pre-market [2] Ambitions Enterprise Management Co LLC - Ambitions Enterprise Management Co LLC (NASDAQ:AHMA) dipped 7.9% to $28.30 in pre-market trading after a 17% drop on Friday, despite reporting a year-over-year increase in H1 EPS results [2] Regencell Bioscience Holdings Ltd - Regencell Bioscience Holdings Ltd (NASDAQ:RGC) fell 6% to $29.52 in pre-market trading after a 2% gain on Friday [2] Sierra Bancorp - Sierra Bancorp (NASDAQ:BSRR) declined 5.8% to $33.02 in pre-market trading [2] Forward Industries Inc - Forward Industries Inc (NASDAQ:FWDI) declined 4.6% to $7.46 in pre-market trading [2] Argo Blockchain PLC - Argo Blockchain PLC – ADR (NASDAQ:ARBK) fell 3.8% to $4.20 in pre-market trading [2] MINISO Group Holding Ltd - MINISO Group Holding Ltd – ADR (NYSE:MNSO) declined 3.6% to $19.12 in pre-market trading [2] Corvus Pharmaceuticals Inc - Corvus Pharmaceuticals Inc (NASDAQ:CRVS) fell 3.2% to $24.17 in pre-market trading after announcing the closing of an upsized public offering of common stock, generating gross proceeds of approximately $201 million [2]

Core Viewpoint - Miniso (09896.HK) announced a share buyback on January 26, 2026, spending HKD 1.9707 million to repurchase 52,600 shares at a price range of HKD 37.08 to 38 per share [1] Group 1 - The total expenditure for the share buyback was HKD 1.9707 million [1] - The number of shares repurchased was 52,600 [1] - The price range for the repurchase was between HKD 37.08 and 38 per share [1]

Core Viewpoint - Miniso Group (09896) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 52,600 shares at a total cost of HKD 1.9707 million [1] - The buyback price per share ranges from HKD 37.08 to HKD 38.00 [1]